ANPAC BIO MED SCIENCE CO LTD's ticker is ANPC and the CUSIP is 03635R107. A total of 7 filers reported holding ANPAC BIO MED SCIENCE CO LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -88.2% | 25,000 | -78.6% | 0.00% | – |
| Q2 2022 | $34,000 | -33.3% | 116,628 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -64.1% | 116,628 | 0.0% | 0.00% | – |
| Q4 2021 | $142,000 | -62.4% | 116,628 | 0.0% | 0.00% | – |
| Q3 2021 | $378,000 | -23.0% | 116,628 | 0.0% | 0.00% | – |
| Q2 2021 | $491,000 | -29.8% | 116,628 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $699,000 | +13.1% | 116,628 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $618,000 | – | 116,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HBK Sorce Advisory LLC | 19,126 | $81,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,677 | $66,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 116,628 | $491,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 17,284 | $73,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,177 | $5,000 | 0.00% |
| UBS Group AG | 2,765 | $12,000 | 0.00% |